Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 13.01B | 12.84B | 12.89B | 12.59B | 11.57B | 10.84B |
Gross Profit | 2.19B | 2.16B | 2.28B | 2.31B | 2.15B | 1.96B |
EBITDA | 433.57M | 797.05M | 828.20M | 655.18M | 873.32M | 965.24M |
Net Income | 104.12M | 148.63M | 249.24M | 117.14M | 190.79M | 179.78M |
Balance Sheet | ||||||
Total Assets | 17.42B | 16.87B | 17.01B | 16.99B | 15.64B | 16.60B |
Cash, Cash Equivalents and Short-Term Investments | 2.52B | 2.39B | 3.15B | 3.65B | 3.26B | 3.46B |
Total Debt | 2.74B | 2.30B | 2.03B | 2.66B | 1.98B | 2.35B |
Total Liabilities | 7.41B | 6.66B | 7.02B | 7.29B | 6.34B | 6.79B |
Stockholders Equity | 9.64B | 9.80B | 9.62B | 9.30B | 8.90B | 9.43B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -617.93M | 180.74M | -226.84M | 201.83M | 708.77M |
Operating Cash Flow | 0.00 | 246.92M | 508.99M | 464.80M | 529.34M | 1.08B |
Investing Cash Flow | 0.00 | -1.17B | -345.73M | -745.35M | -441.94M | -431.48M |
Financing Cash Flow | 0.00 | 116.41M | -762.08M | 606.48M | -478.57M | -306.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ¥4.08B | 25.66 | 0.98% | 3.38% | -10.14% | ||
71 Outperform | ¥2.75B | 12.33 | 3.36% | 4.46% | -27.53% | ||
62 Neutral | ¥3.02B | 32.91 | 2.14% | -4.02% | -60.20% | ||
57 Neutral | £2.52B | 6.00 | -0.23% | 45.97% | 10.33% | 5.64% | |
56 Neutral | ¥2.58B | 102.28 | 1.43% | 19.50% | ― | ||
46 Neutral | ¥5.07B | 521.41 | 2.55% | 1.73% | -914.83% |